{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:29:38Z","timestamp":1761017378259,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.vascn.2022.107211","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T11:58:29Z","timestamp":1661169509000},"page":"107211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["QT Ratio: A simple solution to individual QT correction"],"prefix":"10.1016","volume":"117","author":[{"given":"Nicholas D.","family":"Ether","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek J.","family":"Leishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc B.","family":"Bailie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Adam","family":"Lauver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vascn.2022.107211_bb0005","doi-asserted-by":"crossref","first-page":"14269","DOI":"10.1038\/s41598-021-93774-9","article-title":"Influence of heart rate correction formulas on QTc interval stability","volume":"11","author":"Andr\u0161ov\u00e1","year":"2021","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.vascn.2022.107211_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2010.11.091","article-title":"Occurrence and variance of ECG waveform abnormalities in canines and non-human primates: What is considered normal?","volume":"62","author":"Atterson","year":"2010","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"3","key":"10.1016\/j.vascn.2022.107211_bb0015","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1023\/A:1016393328485","article-title":"Individual patterns of QT\/RR relationship","volume":"6","author":"Batchvarov","year":"2002","journal-title":"Cardiac Electrophysiology Review"},{"issue":"6","key":"10.1016\/j.vascn.2022.107211_bb0020","doi-asserted-by":"crossref","first-page":"H2356","DOI":"10.1152\/ajpheart.00860.2001","article-title":"QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability","volume":"282","author":"Batchvarov","year":"2002","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"11","key":"10.1016\/j.vascn.2022.107211_bb0025","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1088\/0967-3334\/34\/11\/1435","article-title":"Decoupling of QT interval variability from heart rate variability with ageing","volume":"34","author":"Baumert","year":"2013","journal-title":"Physiological Measurement"},{"key":"10.1016\/j.vascn.2022.107211_bb0030","first-page":"353","article-title":"An analysis of the time-relations of electrocardiograms","volume":"7","author":"Bazett","year":"1920","journal-title":"Heart"},{"issue":"5 Suppl 1","key":"10.1016\/j.vascn.2022.107211_bb0035","first-page":"1","article-title":"The QT interval","volume":"43","author":"Bednar","year":"2001","journal-title":"Progress in Cardiovascular Diseases"},{"issue":"5","key":"10.1016\/j.vascn.2022.107211_bb0040","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1517\/14656566.1.5.947","article-title":"Drugs that prolong QT interval as an unwanted effect: Assessing their likelihood of inducing hazardous cardiac dysrhythmias","volume":"1","author":"Cavero","year":"2000","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.vascn.2022.107211_bb0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1542-474X.2005.00593.x","article-title":"Assessment of the stability of the individual-based correction of QT interval for heart rate","volume":"10","author":"Couderc","year":"2005","journal-title":"Annals of Noninvasive Electrocardiology\u202f: The Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc"},{"issue":"1","key":"10.1016\/j.vascn.2022.107211_bb0050","article-title":"QT correction using Bazett\u2019s formula remains preferable in long QT syndrome type 1 and 2","volume":"26","author":"Dahlberg","year":"2021","journal-title":"Annals of Noninvasive Electrocardiology\u202f: The Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc"},{"key":"10.1016\/j.vascn.2022.107211_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2021.107126","article-title":"Improving corrected QT; why individual correction is not enough","volume":"113","author":"Ether","year":"2022","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"2","key":"10.1016\/j.vascn.2022.107211_bb0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1542-474X.2005.05615.x","article-title":"Individual QT-R-R relationship: Average stability over time does not rule out an individual residual variability: Implication for the assessment of drug effect on the QT interval","volume":"10","author":"Extramiana","year":"2005","journal-title":"Annals of Noninvasive Electrocardiology\u202f: the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc"},{"issue":"6","key":"10.1016\/j.vascn.2022.107211_bb0065","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ahj.2012.02.023","article-title":"Methodologies to characterize the QT\/corrected QT interval in the presence of drug-induced heart rate changes or other autonomic effects","volume":"163","author":"Garnett","year":"2012","journal-title":"American Heart Journal"},{"issue":"7","key":"10.1016\/j.vascn.2022.107211_bb0070","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/bjp.2008.275","article-title":"The cardiovascular and pharmacokinetic profile of dofetilide in conscious telemetered beagle dogs and cynomolgus monkeys","volume":"154","author":"Haushalter","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2022.107211_bb0075","first-page":"694","article-title":"Bazett\u2019s QT correction reviewed: Evidence that a linear QT correction for heart rate is better","volume":"1","author":"Hodges","year":"1983","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/j.vascn.2022.107211_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.vascn.2013.05.004","article-title":"Preclinical QT safety assessment: Cross-species comparisons and human translation from an industry consortium","volume":"69","author":"Holzgrefe","year":"2014","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2022.107211_bb0085","series-title":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use","article-title":"ICH S7B: The non-clinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals","author":"ICH","year":"2005"},{"key":"10.1016\/j.vascn.2022.107211_bb0090","series-title":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use","article-title":"ICH E14: The clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non- antiarrhythmic drugs","author":"ICH","year":"2005"},{"key":"10.1016\/j.vascn.2022.107211_bb0095","series-title":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use","article-title":"ICH E14\/S7B implementation working group:clinical and nonclinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential questions and answers","author":"ICH Working Group","year":"2022"},{"issue":"4","key":"10.1016\/j.vascn.2022.107211_bb0100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1542-474X.2006.00120.x","article-title":"Magnitude of error introduced by application of heart rate correction formulas to the canine QT interval","volume":"11","author":"King","year":"2006","journal-title":"Annals of Noninvasive Electrocardiology\u202f: the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc"},{"issue":"3","key":"10.1016\/j.vascn.2022.107211_bb0105","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.vascn.2006.10.001","article-title":"Evaluation of QT interval using a linear model in individual cynomolgus monkeys","volume":"55","author":"Koga","year":"2007","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"5","key":"10.1016\/j.vascn.2022.107211_bb0110","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00002018-200124050-00001","article-title":"Evaluation of drug-induced QT interval prolongation: Implications for drug approval and labelling","volume":"24","author":"Malik","year":"2001","journal-title":"Drug Safety"},{"issue":"3","key":"10.1016\/j.vascn.2022.107211_bb0115","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/heart.87.3.220","article-title":"Relation between QT and RR intervals is highly individual among healthy subjects: Implications for heart rate correction of the QT interval","volume":"87","author":"Malik","year":"2002","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.vascn.2022.107211_bb0120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s40264-018-0736-1","article-title":"Implications of individual QT\/RR profiles-part 1: Inaccuracies and problems of population-specific QT\/heart rate corrections","volume":"42","author":"Malik","year":"2019","journal-title":"Drug Safety"},{"issue":"1","key":"10.1016\/j.vascn.2022.107211_bb0125","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1538\/expanim.51.465","article-title":"Rate-correction technique for QT interval in long-term telemetry ECG recording in beagle dogs","volume":"51","author":"Miyazaki","year":"2002","journal-title":"Experimental Animals"},{"issue":"1","key":"10.1016\/j.vascn.2022.107211_bb0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1538\/expanim.19-0009","article-title":"Establishment of a new formula for QT interval correction using a large colony of cynomolgus monkeys","volume":"69","author":"Nakayama","year":"2020","journal-title":"Experimental Animals"},{"issue":"8","key":"10.1016\/j.vascn.2022.107211_bb0135","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/jcph.1258","article-title":"Individual-specific QT interval correction for drugs with substantial heart rate effect using Holter ECGs extracted over a wide range of heart rates","volume":"58","author":"Panicker","year":"2018","journal-title":"Journal of Clinical Pharmacology"},{"issue":"10","key":"10.1016\/j.vascn.2022.107211_bb0140","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"The New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.vascn.2022.107211_bb0145","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/bjp.2008.222","article-title":"Key clinical considerations for demonstrating the utility of preclinical models to predict clinical drug-induced torsades de pointes","volume":"154","author":"Sager","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"7","key":"10.1016\/j.vascn.2022.107211_bb0150","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0002-9149(92)90562-D","article-title":"An improved method for adjusting the QT interval for heart rate (the Framingham heart study)","volume":"70","author":"Sagie","year":"1992","journal-title":"The American Journal of Cardiology"},{"issue":"5","key":"10.1016\/j.vascn.2022.107211_bb0155","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1254\/jphs.QT-B6","article-title":"QT PRODACT: Inter-facility variability in electrocardiographic and hemodynamic parameters in conscious dogs and monkeys","volume":"99","author":"Sasaki","year":"2005","journal-title":"Journal of Pharmacological Sciences"},{"issue":"2","key":"10.1016\/j.vascn.2022.107211_bb0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1385\/CT:6:2:145","article-title":"Different species require different correction factors for the QT interval","volume":"6","author":"Soloviev","year":"2006","journal-title":"Cardiovascular Toxicology"},{"issue":"1","key":"10.1016\/j.vascn.2022.107211_bb0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vascn.2005.02.005","article-title":"Correction of QT values to allow for increases in heart rate in conscious beagle dogs in toxicology assessment","volume":"53","author":"Tattersall","year":"2006","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"6","key":"10.1016\/j.vascn.2022.107211_bb0170","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003264","article-title":"Which QT correction formulae to use for QT monitoring?","volume":"5","author":"Vandenberk","year":"2016","journal-title":"Journal of the American Heart Association"},{"issue":"2","key":"10.1016\/j.vascn.2022.107211_bb0175","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/cpt.2029","article-title":"Time for a fully integrated nonclinical-clinical risk assessment to streamline QT prolongation liability determinations: A pharma industry perspective","volume":"109","author":"Vargas","year":"2021","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/j.vascn.2022.107211_bb0180","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.vascn.2011.03.002","article-title":"Pharmacokinetic-pharmacodynamic modelling of the effect of moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys","volume":"63","author":"Watson","year":"2011","journal-title":"Journal of Pharmacological and Toxicological Methods"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871922000582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871922000582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:05:50Z","timestamp":1761005150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871922000582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":36,"alternative-id":["S1056871922000582"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2022.107211","relation":{},"ISSN":["1056-8719"],"issn-type":[{"type":"print","value":"1056-8719"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"QT Ratio: A simple solution to individual QT correction","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2022.107211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107211"}}